Study Comparing Valganciclovir Versus Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2010-08-19
- Last Posted Date
- 2012-12-10
- Lead Sponsor
- Pierrel Research Europe GmbH
- Target Recruit Count
- 212
- Registration Number
- NCT01185223
- Locations
- π¦πΉ
Pierrel Site 50, Vienna, Austria
π©πͺPierrel Site 12, Berlin, Germany
π©πͺPierrel Site 13, Berlin, Germany
Β© Copyright 2024. All Rights Reserved by MedPath